Search | IOVS | ARVO Journals

Showing 1 – 20 of 23

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2019

Real-world outcomes from the 3-year European ILUVIEN (0.19 mg fluocinolone acetonide implant) RegIstry Safety Study (IRISS)

Frank HJ Koch; Usha Chakravarthy; Ramin Khoramnia; Simon Taylor; Clare Bailey; João Sousa

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2622. doi: https://doi.org/

ARVO Annual Meeting Abstract July 2019

Aflibercept in the real world – an EPR based clinical audit of patients with diabetic macular edema from 21 UK hospitals

Sajjad Mahmood; Irene Mary Stratton; Raj Mukherjee; James S Talks; Clare Bailey; Andrew Lotery; Shahram Kashani; Faruque Ghanchi; Salim Natha; Peter Henry Scanlon

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2626. doi: https://doi.org/

ARVO Annual Meeting Abstract July 2019

Earlier intervention is associated with improved visual outcomes in patients with persistent or recurrent diabetic edema - Clinical insights from the ILUVIEN (fluocinolone acetonide) Registry Safety Study (IRISS)

Panos Vouzounis; Simon Taylor; Usha Chakravarthy; Clare Bailey; Frank HJ Koch; João Sousa

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2630. doi: https://doi.org/

Retina February 2019

An Evaluation of a Battery of Functional and Structural Tests as Predictors of Likely Risk of Progression of Age-Related Macular Degeneration

PDF

D. Grant Robinson; Tom H. Margrain; Clare Bailey; Alison M. Binns
TAGS: age-related macular degeneration, dark adaptation, outcome measures, photopsia, retinal cone, severity of illness, vision, drusen, retina, eye
Invest. Ophthalmol. Vis. Sci.. 2019; 60(2):580-589. doi: https://doi.org/10.1167/iovs.18-25092

Includes: Supplemental Content

Retina September 2018

Low-Level Nighttime Light Therapy for Age-Related Macular Degeneration: A Randomized Clinical Trial

PDF

D. Grant Robinson; Tom H. Margrain; Matt J. Dunn; Clare Bailey; Alison M. Binns
TAGS: age-related macular degeneration, clinical trials, masks, phototherapy, ultraviolet therapy, outcome measures, drusen, safety, dark adaptation, disease progression
Invest. Ophthalmol. Vis. Sci.. 2018; 59(11):4531-4541. doi: https://doi.org/10.1167/iovs.18-24284

Includes: Supplemental Content

ARVO Annual Meeting Abstract July 2018

Audit of anti-VEGF injections for diabetic macula edema in 21 UK hospitals

Peter Henry Scanlon; Irene Stratton; Clare Bailey; Haralobos Eleftheriadis; Naren Dhingra; James S Talks; Tunde Peto

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3607. doi: https://doi.org/

ARVO Annual Meeting Abstract July 2018

United Kingdom multicenter Medisoft™ electronic medical record real-world audit following implant of ILUVIEN ® (fluocinolone acetonide 190 µg) – the first 3-year results from the UK

Fahd Quhill; Clare Bailey; Usha Chakravarthy; Andrew Lotery; Geeta Menon; James S Talks

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1906. doi: https://doi.org/

ARVO Annual Meeting Abstract June 2017

Progression from early/intermediate age-related macular degeneration to either geographic atrophy or choroidal neovascularisation in a large UK cohort

Usha Chakravarthy; Clare Bailey; Martin McKibbin; Sarah Rabhi; Anushini Muthutantri; Christopher Brittain; Jeffrey R Willis; Ronald A Cantrell

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2979. doi: https://doi.org/

ARVO Annual Meeting Abstract June 2017

Clinical Features Predict Diabetic Retinopathy Progression

Cecilia S Lee; Aaron Y Lee; Doug Baughman; Atul Varma; Salim Natha; Louise Downey; Geeta Menon; Sajjad Mahmood; Usha Chakravarthy; David Paul Crabb; Alastair K Denniston; Clare Bailey; Adnan Tufail; Catherine A Egan

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4283. doi: https://doi.org/

ARVO Annual Meeting Abstract June 2017

UK Multi-centre Medisoft EMR audit of intra-operative pressure event following implant of ILUVIEN ® (fluocinolone acetonide 190 μg).

Fahd Quhill; Clare Bailey; Usha Chakravarthy; Andrew J Lotery; Geeta Menon; James Talks

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4622. doi: https://doi.org/

ARVO Annual Meeting Abstract June 2017

The impact of prior steroid therapy on safety outcomes following treatment with ILUVIEN (fluocinolone acetonide) – An analysis of intra-ocular outcomes (IOP) from UK electronic medical records.

Serena Salvatore; Clare Bailey; Usha Chakravarthy; Andrew J Lotery; Geeta Menon; James Talks

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4631. doi: https://doi.org/

ARVO Annual Meeting Abstract June 2017

Quantification of flow at baseline and follow-up in uveitic and non-age-related macular degeneration choroidal neovascular membranes (CNVM) using Optical Coherence Tomography-Angiography (OCT-A).

Tomas Burke; Ester Carreno; Clare Bailey; Richard W J Lee; Andrew D Dick; Adam H Ross

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1643. doi: https://doi.org/

ARVO Annual Meeting Abstract June 2017

New staging of Acute Posterior Multifocal Placoid Pigment Epiteliopathy by using multimodal imaging

Ester Carreno; Tomas Burke; Colin Chu; Serena Salvatore; Richard W J Lee; Clare Bailey; Andrew D Dick; Adam H Ross

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):5995. doi: https://doi.org/

Articles February 2017

Platform-Independent Cirrus and Spectralis Thickness Measurements in Eyes with Diabetic Macular Edema Using Fully Automated Software

PDF

Alex S. Willoughby; Stephanie J. Chiu; Rachel K. Silverman; Sina Farsiu; Clare Bailey; Henry E. Wiley; Frederick L. Ferris, III; Glenn J. Jaffe
TAGS: eye, macular edema, diabetic, software
Trans. Vis. Sci. Tech.. 2017; 6(1):9. doi: https://doi.org/10.1167/tvst.6.1.9

ARVO Annual Meeting Abstract September 2016

Real-life outcomes of switching AntiVEGF treatment from ranibizumab to aflibercept for neovascular agerelated macular degeneration (nAMD): UK multicentre study.

Faruque Daudbhai Ghanchi; Nishal Patel; James S Talks; Andrew J Lotery; Sobha Sivaprasad; Clare Bailey; Rob Johnston; Martin McKibbin

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3334. doi: https://doi.org/

ARVO Annual Meeting Abstract September 2016

Automated diabetic retinopathy image assessment softwares: large scale, real world evaluation of diagnostic accuracy and cost-effectiveness compared to human graders

Catherine A Egan; Alicja Rudnicka; Christopher Owen; Caroline Rudisill; Sebastian Salas-Vega; Paul Taylor; Gerald Liew; Aaron Lee; Clare Bailey; john anderson; Adnan Tufail

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12) doi: https://doi.org/

ARVO Annual Meeting Abstract September 2016

Previous intravitreal therapy is associated with increased risk of posterior capsule rupture during cataract surgery.

Alex C Day; Aaron Lee; Catherine A Egan; Clare Bailey; Robert Johnston; Marie Tsaloumas; Alastair K Denniston; Adnan Tufail

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12) doi: https://doi.org/

ARVO Annual Meeting Abstract June 2015

A randomized 36-week crossover trial comparing ranibizumab and bevacizumab for diabetic macular edema

Henry Wiley; Clare Bailey; Catherine A Cukras; Glenn J Jaffe; Richard W J Lee; Erin Loken; Catherine Meyerle; Darby J.S. Thompson; Wai T Wong; Frederick L Ferris

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3149. doi: https://doi.org/

ARVO Annual Meeting Abstract June 2015

Cardiovascular and cerebrovascular safety of ranibizumab 0.5 mg in diabetic macular edema

Marco A Zarbin; Focke Ziemssen; Philippe Margaron; Howard Snow; Cornelia Dunger-Baldauf; Ron Hashmonay; Clare Bailey

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1410. doi: https://doi.org/

ARVO Annual Meeting Abstract June 2015

Prospective case series of Ranibizumab for the treatment of inflammatory and idiopathic choroidal neovascular membranes.

Ester Carreno; Tanya Moutray; Kostantinos Fotis; Richard W J Lee; Andrew D Dick; Adam H Ross; Clare Bailey

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):196. doi: https://doi.org/

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Real-world outcomes from the 3-year European ILUVIEN (0.19 mg fluocinolone acetonide implant) RegIstry Safety Study (IRISS)

Aflibercept in the real world – an EPR based clinical audit of patients with diabetic macular edema from 21 UK hospitals

Earlier intervention is associated with improved visual outcomes in patients with persistent or recurrent diabetic edema - Clinical insights from the ILUVIEN (fluocinolone acetonide) Registry Safety Study (IRISS)

An Evaluation of a Battery of Functional and Structural Tests as Predictors of Likely Risk of Progression of Age-Related Macular Degeneration

Low-Level Nighttime Light Therapy for Age-Related Macular Degeneration: A Randomized Clinical Trial

Audit of anti-VEGF injections for diabetic macula edema in 21 UK hospitals

United Kingdom multicenter Medisoft™ electronic medical record real-world audit following implant of ILUVIEN ® (fluocinolone acetonide 190 µg) – the first 3-year results from the UK

Progression from early/intermediate age-related macular degeneration to either geographic atrophy or choroidal neovascularisation in a large UK cohort

Clinical Features Predict Diabetic Retinopathy Progression

UK Multi-centre Medisoft EMR audit of intra-operative pressure event following implant of ILUVIEN ® (fluocinolone acetonide 190 μg).

The impact of prior steroid therapy on safety outcomes following treatment with ILUVIEN (fluocinolone acetonide) – An analysis of intra-ocular outcomes (IOP) from UK electronic medical records.

Quantification of flow at baseline and follow-up in uveitic and non-age-related macular degeneration choroidal neovascular membranes (CNVM) using Optical Coherence Tomography-Angiography (OCT-A).

New staging of Acute Posterior Multifocal Placoid Pigment Epiteliopathy by using multimodal imaging

Platform-Independent Cirrus and Spectralis Thickness Measurements in Eyes with Diabetic Macular Edema Using Fully Automated Software

Real-life outcomes of switching AntiVEGF treatment from ranibizumab to aflibercept for neovascular agerelated macular degeneration (nAMD): UK multicentre study.

Automated diabetic retinopathy image assessment softwares: large scale, real world evaluation of diagnostic accuracy and cost-effectiveness compared to human graders

Previous intravitreal therapy is associated with increased risk of posterior capsule rupture during cataract surgery.

A randomized 36-week crossover trial comparing ranibizumab and bevacizumab for diabetic macular edema

Cardiovascular and cerebrovascular safety of ranibizumab 0.5 mg in diabetic macular edema

Prospective case series of Ranibizumab for the treatment of inflammatory and idiopathic choroidal neovascular membranes.

To View More...

You must be signed into an individual account to use this feature.